TIMPs and MMPs expression in CSF from patients with TSP/HAM. (Q39130171)

9 September 2017

title

TIMPs and MMPs expression in CSF from patients with TSP/HAM. (English)

1 reference

9 September 2017

Ana M Kettlun

1 reference

9 September 2017

Luis Cartier

1 reference

9 September 2017

Lorena García

1 reference

9 September 2017

Lucía Collados

1 reference

9 September 2017

Felipe Vásquez

1 reference

9 September 2017

Eugenio Ramírez

1 reference

9 September 2017

M Antonieta Valenzuela

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

1 reference

9 September 2017

page(s)

2863-2876

1 reference

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: an axomyelinic degeneration of the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases and diseases of the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Tissue inhibitors of metalloproteinases: evolution, structure and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Differential expression of matrix metalloproteinases in bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Molecular pathogenesis of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: relevance to HTLV-I-induced neurological disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Human T-cell leukemia virus type I Tax transactivates the matrix metalloproteinase-9 gene: potential role in mediating adult T-cell leukemia invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Human T cell leukemia virus type I and neurologic disease: events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in 10 Chilean seronegative patients with tropical spastic paraparesis or HTLV-I-associated myelopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900146-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(03)00146-2

1 reference

9 September 2017

1 reference